Clinical Trial: Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Participants

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915024) titled 'Phase 1 Study to Assess the Effects of HSK31858 on the QT/QTc Interval in Healthy Chinese Pa... Read More

Clinical Trial: Proof-of-concept for Use of Transcutaneous Spinal Stimulation (TSS) With the ExaStim(R) Stimulation System in Adults With Chronic Ischemic Stroke

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917221) titled 'Proof-of-concept for Use of Transcutaneous Spinal Stimulation (TSS) With the ExaStim(R) Stim... Read More

Clinical Trial: Compression-Only Versus Standard Basic Life Support Training in Nursing Students

U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07915778) titled 'Compression-Only Versus Standard Basic Life Support Training in Nursing Students' on Oct. 21... Read More

Zerodha Mutual Fund announces change in scheme names

Mumbai, Nov. 5 -- Zerodha Mutual Fund has announced change in scheme names under the following schemes, with effect from 02 November 2026. Table, th, td {border: 1px Solid black; Border-collapse: co... Read More

Singapore Clinical Trial: FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'FRAmework-01: A Three-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or... Read More

Singapore Clinical Trial: A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Versus Standard of Care as Maintenance Treatment After 2L Platinum-Based Doublet Chemotherapy in Participants With Recurrent Platinum- Sensitive Ovarian Cancer (PSOC)

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-Label, Phase 3 Study of Rinatabart Sesutecan (Rina-S) Plus Standard of Care Vers... Read More

Singapore Clinical Trial: An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembrolizumab Versus Chemotherapy in Subjects with Previously Untreated Locally Advanced or Metastatic Urothelial Carcinoma that Expresses HER2 (IHC 1+ and Greater)

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'An Open-label, Randomized, Controlled Phase 3 Study of Disitamab Vedotin in Combination with Pembro... Read More

Singapore Clinical Trial: A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Platinum-Based Chemotherapy ± Bevacizumab as 2L Treatment in Participants With Recurrent Platinum-Sensitive Ovarian Cancer

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pla... Read More

Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More

Singapore Clinical Trial: ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants with Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More

• ««
• «
• 3710
• 3711
• 3712
• 3713
• 3714
• 3715
• 3716
• 3717
• 3718
• 3719
• »
• »»